Repetitive transcranial magnetic stimulation promotes neural stem cell proliferation via the regulation of mir-25 in a rat model of focal cerebral ischemia

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Guo, Feng ^a   Han, Xiaohua ^a   Zhang, Jinghui ^b   Zhao, Xiuxiu ^a   Lou, Jicheng ^c   Chen, Hong ^a   Huang, Xiaolin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; MICRORNA; MICRORNA 25; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; MIRN25 MICRORNA, RAT;

ADULT STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FOCAL CEREBRAL ISCHEMIA; GENE EXPRESSION; GENE TARGETING; MALE; NEURAL STEM CELL; NONHUMAN; P57 GENE; PTEN GENE; RAT; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SIGNAL TRANSDUCTION; SUBVENTRICULAR ZONE; TRANSCRANIAL MAGNETIC STIMULATION; UPREGULATION; ANIMAL; BRAIN INFARCTION; CYTOLOGY; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BRAIN ISCHEMIA; CELL PROLIFERATION; CEREBRAL CORTEX; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; MALE; MICRORNAS; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRANIAL MAGNETIC STIMULATION; UP-REGULATION;

EID: 84907813002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109267     Document Type: Article

References (55)

1. Wu XM, Zhu B, Fu LY, Wang HL, Shi JP, et al. (2013) Prevalence, incidence, and mortality of stroke in the chinese island populations: a systematic review. PLoS One 8: e78629.
2. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (New York, NY) 255: 1707-1710. http://dx.doi.org/10.1126/science.1553558.
3. Kee NJ, Preston E, Woitowicz JM (2001) Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat. Exp Brain Res 136: 313-320.
4. Yagita Y, Kitagawa K, Ohtsuki T, Takasawa K, Miyata T, et al. (2001) Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke 32: 1890-1896.
5. Ueyama E, Ukai S, Ogawa A, Yamamoto M, Shinosaki K, et al. (2011) Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats. Psychiatry and Clinical Neurosciences 65: 77-81.
6. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Johnson JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
7. Foshay KM, Gallicano GI (2009) miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol 326: 431-443.
8. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Cleary MA, et al. (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174.
9. Brett JO, Renault VM, Rafalski VA, Webb AE, Brunet A (2011) The microRNA cluster miR-106b, 25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging 3: 108-124.
10. Peck B, Schulze A (2011) A role for the cancer-associated miR-106b∼25 cluster in neuronal stem cells. Aging (Albany NY) 3: 329-331.
11. Jeyaseelan K, Lim KY and Armugam A (2008) MicroRNA Expression in the Blood and Brain of Rats Subjected to Transient Focal Ischemia by Middle Cerebral Artery Occlusion. Stroke 39: 959-966.
12. Xu X, Chen Z, Zhao X, Wang J, He J, et al. (2012) MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochemical and Biophysical Research Communications 421: 640-645.
13. Zhao ZN, Bai JX, Zhou Q, Yan B, Yang AG, et al. (2012) TSA suppresses miR-106b-93∼25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC. PLoS One 7: e45133.
14. Poliseno L, Salmena L, Riccardi L, Fornari A, Pandolfi PP, et al. (2010) Identification of the miR-106b, 25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29.
15. Liu Y, Zhang Y, Wen J, Liu L, Hu Z, et al. (2012) A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 7: e32230.
16. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Stoffel M, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
17. Elmen J, Lindow M, Schutz S, Lawrence M, Kauppinen S, et al. (2008) LNAmediated microRNA silencing in non-human primates. Nature 452: 896-899.
18. Dharap A, Bowen K, Place R, Li LC, Vemuganti R (2009) Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 29: 675-687.
19. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
20. Lin XJ, Miao P, Wang JX, Yuan FL, Yang GY, et al. (2013) Surgery-Related Thrombosis Critically Affects the Brain Infarct Volume in Mice Following Transient Middle Cerebral Artery Occlusion. PloS One 8: e75561.
21. Chen J, Li Y, Wang L, Zhang Z, Chopp M, et al. (2001) Therapeutic Benefit of Intravenous Administration of Bine Marrow Stromal Cells After Cerebral Ischemia in Rats. Stroke 32: 1005-1011.
22. Deng ZD, Lisanby SH, Peterchev AV (2014) Coil design considerations for deep transcranial magnetic stimulation. Clin Neurophysiol 125: 1202-12.
23. Linden RD, Zhang YP, Burke DA, Burke DA, Shields CB, et al. (1999) Magnetic motor evoked potential monitoring in the rat. J Neurosurg 91: 205-210.
24. Isayama K, Pitts LH, Nishimura MC (1991) Evaluation of 2, 3, 5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 22: 1394-1398.
25. Dziennis S, Mader S, Akiyoshi K, Ren X, Offner HA, et al. (2011) Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis 26: 123-33.
26. Sonkoly E, Wei T, Janson PC, Sääf A, Pivarcsi A, et al. (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2: e610.
27. Taupin P (2007) BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev 53: 198-214.
28. Gao F, Wang S, Guo Y, Wang J, Zhang H, et al. (2010) Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischaemia: a microPET study. Eur J Nucl Med Mol Imaging 37: 954-961.
29. Yoon KJ, Lee YT, Han TR (2011) Mechanism of functional recovery after repetitive transcranial magnetic stimulation (rTMS) in the subacute cerebral ischemic rat model: neural plasticity or anti-apoptosis? Exp Brain Res 214: 549-556.
30. Lang N, Harms J, Weyh T, Lemon RN, Siebner HR, et al. (2006) Stimulus intensity and coil characteristics influence the efficacy of rTMS to suppress cortical excitability. Clin Neurophysiol 117: 2292-2301.
31. Kim YH, You SH, Ko MH, Park JW, Hallett M, et al. (2006) Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke 37: 1471-1476.
32. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A (2006) Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord 21: 2201-2205.
33. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Hallett M, et al. (2006) Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 21: 325-331.
34. Le Q, Qu Y, Tao Y, Zhu S (2014) Effects of repetitive transcranial magnetic stimulation on hand function recovery and excitability of the motor cortex after stroke: a meta-analysis. Am J Phys Med Rehabil 93: 422-30.
35. Rossi S, Hallett M, Rossini PM, Pascual-Leone A (2009) Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research Clin Neurophysiol 120: 2008-39.
36. Corti M, Patten C, Triggs WC (2012) Patten and W. Triggs, Repetitive transcranial magnetic stimulation of motor cortex after stroke: a focused review. Am J Phys Med Rehabil 91: 254-70.
37. Hiscock A, Miller S, Rothwell J, Tallis RC, Pomeroy VM (2008) Informing dose-finding studies of repetitive transcranial magnetic stimulation to enhance motor function: a qualitative systematic review. Neurorehabil Neural Repair 22: 228-49.
38. Kwon TG, Kim YH, Chang WH, Bang OY, Shin YI (2014) Effective method of combining rTMS and motor training in stroke patients. Restor Neurol Neurosci 32: 223-32.
39. Sasaki N, Mizutani S, Kakuda W, Abo M (2013) Comparison of the effects of high- and low-frequency repetitive transcranial magnetic stimulation on upper limb hemiparesis in the early phase of stroke. J Stroke Cerebrovasc Dis 22: 413-8.
40. Feng SF, Shi TY, Fan-Yang, Wang WN, Tan QR, et al. (2012) Long-lasting effects of chronic rTMS to treat chronic rodent model of depression. Behav Brain Res 232: 245-51.
41. Yozbatiran N, Alonso-Alonso M, See J, Demirtas-Tatlidede A, Cramer SC, et al, (2009) Safety and behavioral effects of high-frequency repetitive transcranial magnetic stimulation in stroke. Stroke 40: 309-12.
42. Lomarev MP, Kim DY, Richardson SP, Voller B, Hallett M (2007) Safety study of high-frequency transcranial magnetic stimulation in patients with chronic stroke. Clin Neurophysiol 118: 2072-5.
43. Hotermans C, Peigneux P, Moonen G, Maertens De Noordhout A, et al. (2007) Therapeutic use of high-frequency repetitive transcranial magnetic stimulation in stroke. Stroke 38: 253.
44. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8: 963-970.
45. Szele FG, Chesselet MF (1996) Cortical lesions induce an increase in cell number and PSA-NCAM expression in the subventricular zone of adult rats. J Comp Neurol 368: 439-454.
46. Arias-Carrion O, Verdugo-Diaz L, Feria-Velasco A, Millan-Aldaco D, Drucker-Colin R, et al. (2004) Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions. J Neurosci Res 78: 16-28.
47. Arias-Carrion O (2008) Basic mechanisms of rTMS: Implications in Parkinson's disease. Int Arch Med 1: 2.
48. Machado S, Bittencourt J, Minc D, Portella CE, Riberio P, et al. (2008) Therapeutic applications of repetitive transcranial magnetic stimulation in clinical neurorehabilitation. Funct Neurol 23: 113-122.
49. Mally J and Stone TW (2007) New advances in the rehabilitation of CNS diseases applying rTMS. Expert Rev Neurother 7: 165-77.
50. Ferrarelli F, Haraldsson HM, Barnhart TE, Roberts AD, Tononi G, et al. (2004) A [17F]-fluoromethane PET/TMS study of effective connectivity. Brain Res Bull 64: 103-13.
51. Arnold CP, Tan R, Zhou B, Yue SB, Chen CZ, et al. (2011) MicroRNA programs in normal and aberrant stem and progenitor cells. Genome Res 21: 798-810.
52. Gangaraju VK, Lin H (2009) MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10: 116-125.
53. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, Stallings RL, Henshall DC, et al. (2011) miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132[J]. Am J Pathol 179: 2519-2532.
54. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, Engel T, Henshall DC, et al. (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18: 1087-1094.
55. Rooke HM, Crosier KE (2001) The smad proteins and TGFbeta signalling: uncovering a pathway critical in cancer. Pathology 33:73-84.